Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Atracurium Besylate Injection, USP, 50mg/5mL and 100mg/10mL Due to FDA Observations Pertaining to Aseptic and GMP Practices at the Manufacturer's Site Potenti